Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer

British Journal of Cancer

Volumn 108, Issue 6, 2013, Pages 1267-1272

  Koskas, M ^a,b   Chereau, E ^c   Ballester, M ^c   Dubernard, G ^d   Lecuru F ^e   Heitz, D ^f   Mathevet, P ^g   Marret, H ^h   Querleu, D ⁱ   Golfier, F ^j   Leblanc, E ^k   Luton, D ^a   Rouzier, R ^l   Darai E ^b  

^a BICHAT HOSPITAL   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c HÔPITAL TENON   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f Obstetrics and Gynecology   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h CHU BRETONNEAU   (France)

ⁱ Department of Surgical Oncology   (France)

^j CENTRE HOSPITALIER LYON SUD   (France)

^k CENTRE OSCAR LAMBRET   (France)

^l INSTITUT CURIE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; ENDOMETRIUM CANCER; ERROR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; PELVIS LYMPH NODE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADENOCARCINOMA, CLEAR CELL; AGED; AREA UNDER CURVE; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; NOMOGRAMS; PELVIC NEOPLASMS; PROGNOSIS; ROC CURVE; SENTINEL LYMPH NODE BIOPSY;

EID: 84876409062     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.95     Document Type: Article

References (25)

1. Ayhan A, Tuncer ZS, Tuncer R, Yuce K, Kucukali T (1995) Tumor status of lymph nodes in early endometrial cancer in relation to lymph node size. Eur J Obstet Gynecol Reprod Biol 60(1): 61-63.
2. Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Darai E (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12: 469-476.
3. Bendifallah S, Genin AS, Naoura I, Chabbert Buffet N, Clavel Chapelon F, Haddad B, Luton D, Darai E, Rouzier R, Koskas M (2012) A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol 207: e1-8.
4. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Croce C, Mangioni C (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100: 1707-1716.
5. Bezu C, Coutant C, Ballester M, Feron JG, Rouzier R, Uzan S, Darai E (2010) Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 29: 5.
6. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ (2003) FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13: 664-672.
7. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM (1999) Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354: 896-900.
8. Delpech Y, Cortez A, Coutant C, Callard P, Uzan S, Darai E, Barranger E (2007) The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol 18: 1799-1803.
9. Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA (2003) Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol 91: 518-525.
10. Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R (1995) Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 425: 617-629.
11. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S (1997) A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65: 82-87.
12. International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335(8705): 1565-1568.
13. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373: 125-136.
14. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689.
15. Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, Podratz KC (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92: 833-838.
16. McCoy A, Finan MA, Boudreaux FT, Tucker JA, Lazarchick JJ, Donnell RM, Rocconi RP (2012) The incidence and clinical significance of lymph node micrometastases determined by immunohistochemical staining in stage I-lymph node negative endometrial cancer. Histol Histopathol 27: 181-185.
17. Miller ME, Langefeld CD, Tierney WM, Hui SL, McDonald CJ (1993) Validation of probabilistic predictions. Med Decis Making 13: 49-58.
18. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgicalpathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65.
19. Niikura H, Okamoto S, Yoshinaga K, Nagase S, Takano T, Ito K, Yaegashi N (2007) Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol 105: 683-686.
20. Pelosi E, Arena V, Baudino B, Bello M, Giusti M, Gargiulo T, Palladin D, Bisi G (2003) Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 24: 971-975.
21. Querleu D, Planchamp F, Narducci F, Morice P, Joly F, Genestie C, Haie-Meder C, Thomas L, Quenel-Tueux N, Darai E, Dorangeon PH, Marret H, Taieb S, Mazeau-Woynar V (2011) Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Societe Francaise d'Oncologie Gynecologique. Int J Gynecol Cancer 21: 945-950.
22. Reich O, Winter R, Pickel H, Tamussino K, Haas J, Petru E (1996) Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int J Gynecol Cancer 6: 445-447.
23. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
24. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375: 1165-1172.
25. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M (2001) Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 80: 139-144.